Tower Research Capital LLC (Trc) Pulmonx Corp Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Pulmonx Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,861 shares of LUNG stock, worth $36,689. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,861
Previous 7,552
22.39%
Holding current value
$36,689
Previous $47,000
2.13%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding LUNG
# of Institutions
124Shares Held
31MCall Options Held
300Put Options Held
204K-
Primecap Management CO Pasadena, CA5.68MShares$35.5 Million0.04% of portfolio
-
Morgan Stanley New York, NY3.79MShares$23.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$16.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$14.3 Million0.0% of portfolio
-
Jefferies Group LLC New York, NY1.2MShares$7.52 Million0.2% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $233M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...